FORTE BIOSCIENCES, INC. Revenue
FORTE BIOSCIENCES, INC. (FBRX) reported Revenue of $36.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2020-04-23
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-12-31 was $9.00K, a 0.00% change year-over-year.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-09-30 was $9.00K, a 99.95% decline year-over-year.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-06-30 was $9.00K, a 0.00% change year-over-year.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2019-03-31 was $9.00K, a 0.00% change year-over-year.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $36.00K, a 99.80% decline from fiscal 2018.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2018 was $18.04M, a 43890.24% increase from fiscal 2017.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2017 was $41.00K, a 16.33% decline from fiscal 2016.
- FORTE BIOSCIENCES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2016 was $49.00K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2019-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $18.00K derived: sum of 2 quarters · filed 2020-02-27 | $27.00K derived: sum of 3 quarters · filed 2020-02-27 | $36.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $9.00K 10-Q · filed 2019-11-12 | $18.00K derived: sum of 2 quarters · filed 2019-11-12 | $27.00K 10-Q · filed 2019-11-12 | $36.00K derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-06-30 | $9.00K 10-Q · filed 2019-08-08 | $18.00K 10-Q · filed 2019-08-08 | $27.00K derived: sum of 3 quarters · filed 2020-04-23 | $18.04M derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-03-31 | $9.00K 10-Q · filed 2020-04-23 | $18.00K derived: sum of 2 quarters · filed 2020-04-23 | $18.03M derived: sum of 3 quarters · filed 2020-04-23 | $18.04M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $18.02M derived: sum of 2 quarters · filed 2020-02-27 | $18.03M derived: sum of 3 quarters · filed 2020-02-27 | $18.04M 10-K · filed 2020-02-27 |
| 2018-09-30 | $18.01M 10-Q · filed 2019-11-12 | $18.02M derived: sum of 2 quarters · filed 2019-11-12 | $18.03M 10-Q · filed 2019-11-12 | $18.04M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $9.00K 10-Q · filed 2019-08-08 | $18.00K 10-Q · filed 2019-08-08 | $28.00K derived: sum of 3 quarters · filed 2020-02-27 | $38.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $9.00K 10-Q · filed 2019-05-07 | $19.00K derived: sum of 2 quarters · filed 2020-02-27 | $29.00K derived: sum of 3 quarters · filed 2020-02-27 | $39.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $20.00K derived: sum of 2 quarters · filed 2020-02-27 | $30.00K derived: sum of 3 quarters · filed 2020-02-27 | $41.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $10.00K 10-Q · filed 2018-11-08 | $20.00K derived: sum of 2 quarters · filed 2018-11-08 | $31.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $10.00K 10-Q · filed 2018-08-09 | $21.00K 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | $49.00K 10-K · filed 2019-02-27 |